PSNL - Personalis Inc
IEX Last Trade
5.45
-0.350 -6.422%
Share volume: 1,336,948
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.80
-0.35
-6.03%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-02-23 | 2023-05-03 | 2023-08-08 | 2023-11-07 | 2024-02-28 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 357.979 M | 317.861 M | 292.700 M | 272.180 M | 249.038 M | 226.636 M | 225.099 M | 195.276 M | |
| Current Assets | 260.040 M | 221.908 M | 199.699 M | 182.772 M | 160.955 M | 148.215 M | 146.744 M | 120.439 M | |
| Inventories | 6.507 M | 5.864 M | 8.591 M | 5.517 M | 4.771 M | 5.127 M | 10.474 M | 8.767 M | |
| Other Current Assets | 7.166 M | 9.696 M | 6.808 M | 10.213 M | 8.845 M | 8.759 M | 4.361 M | 4.908 M | |
| Short Term Investments | 7.166 M | 9.696 M | 6.808 M | 10.213 M | 8.845 M | 8.759 M | 4.361 M | 4.908 M | |
| Total Receivables | 12.877 M | 13.592 M | 16.642 M | 18.103 M | 10.132 M | 13.666 M | 17.730 M | 11.345 M | |
| Current Cash | 233.490 M | 192.756 M | 167.658 M | 148.939 M | 137.207 M | 120.663 M | 114.179 M | 95.419 M | |
| Total Non-current Assets | 97.939 M | 95.953 M | 93.001 M | 89.408 M | 88.083 M | 78.421 M | 78.355 M | 74.837 M | |
| Property Plant Equipment | 47.585 M | 61.219 M | 61.935 M | 61.446 M | 59.486 M | 56.751 M | 57.366 M | 54.529 M | |
| Other Assets | 4.439 M | 4.689 M | 4.586 M | 3.991 M | 3.937 M | 3.503 M | 3.137 M | 2.793 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 357.979 M | 317.861 M | 292.700 M | 272.180 M | 249.038 M | 226.636 M | 225.099 M | 195.276 M | |
| Total liabilities | 93.347 M | 75.462 M | 74.561 M | 78.548 M | 72.952 M | 75.430 M | 95.658 M | 74.582 M | |
| Total current liabilities | 41.506 M | 33.739 M | 33.131 M | 34.143 M | 28.592 M | 32.478 M | 47.234 M | 31.373 M | |
| Accounts Payable | 21.395 M | 10.784 M | 12.854 M | 10.927 M | 8.847 M | 8.963 M | 14.920 M | 9.179 M | |
| Other liabilities | 5.000 K | 374.000 K | 389.000 K | 4.096 M | 4.034 M | 3.786 M | 10.103 M | 5.775 M | |
| Current long term debt | 1.745 M | 2.178 M | 2.218 M | 2.257 M | 430.000 K | 403.000 K | 0.000 | 1.654 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.000 K | 374.000 K | 389.000 K | 4.096 M | 4.034 M | 3.786 M | 10.103 M | 5.775 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 264.632 M | 242.399 M | 218.139 M | 193.632 M | 176.086 M | 151.206 M | 129.441 M | 120.694 M | |
| Common stock | 45.638 M | 45.921 M | 46.264 M | 46.740 M | 47.670 M | 48.694 M | 49.597 M | 50.679 M | |
| Retained earnings | -302.850 M | -329.342 M | -360.410 M | -389.069 M | -413.024 M | -442.122 M | -468.706 M | -481.674 M |